Sequence information
Variant position: 264 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 457 The length of the canonical sequence.
Location on the sequence:
VPEEEGPTVVLNPHPSLGYK
E IRKGESRSEALAVDGAGKPG
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human VPEEEGP-TVVLNPHPSLGYKE IRKGES-RSEALAVDGAGKPG
Mouse GPEEV-P-TAASSSHFHAGYKA IQKDDG-QSDSQAVDGDGK
Rat GPKEV-P-TAASSSHFYSGYKK IQKDDDGQSESQAVNG--K
Bovine VPEEESPPTAAFKPPPSLGNKE TQRAAPGWPE----DGAGK
Horse DAEEEGP-TAAFNPHPSLSYK- IRKGES-WSEALVVDGARK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
19 – 457
Chromogranin-A
Region
88 – 440
Disordered
Modified residue
270 – 270
Phosphoserine
Glycosylation
251 – 251
O-linked (GalNAc...) threonine
Literature citations
Submission
Totoki Y.; Toyoda A.; Takeda T.; Sakaki Y.; Tanaka A.; Yokoyama S.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]; VARIANT ASP-264;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.